Patterns of tocilizumab use, effectiveness and safety in patients with rheumatoid arthritis: core data results from a set of multinational observational studies.

@article{Haraoui2017PatternsOT,
  title={Patterns of tocilizumab use, effectiveness and safety in patients with rheumatoid arthritis: core data results from a set of multinational observational studies.},
  author={Boulos Haraoui and Gustavo da Silva Casado and L{\'a}szl{\'o} Czirj{\'a}k and Andrew L Taylor and Corrado Bernasconi and William Reiss and Roberto Caporali},
  journal={Clinical and experimental rheumatology},
  year={2017},
  volume={35 6},
  pages={899-906}
}
OBJECTIVES To observe patients with rheumatoid arthritis (RA) treated with the interleukin-6 receptor-alpha inhibitor tocilizumab (TCZ) in routine clinical practice. METHODS Data on concomitant medications, effectiveness and safety were pooled from independent, multinational studies in patients with RA initiating intravenous TCZ according to local label recommendations observed in routine practice for 6 months. Patients were grouped by TCZ monotherapy or combination therapy with conventional… CONTINUE READING

Citations

Publications citing this paper.

Tocilizumab: A Review in Rheumatoid Arthritis

Drugs • 2017
View 4 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…